Preliminary scientific studies show conolidine may possibly inhibit specific ion channels, reducing neuronal excitability and limiting suffering indicators. This mechanism is especially appropriate in neuropathic pain, where by abnormal signaling will cause persistent soreness. Moreover, conolidine seems to impact G protein-coupled receptor (GPCR)